Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

The American College of Physicians (ACP) has issued Best Practice Advice for clinicians whose patients are considering or ...

Many physicians who treat patients with chronic back pain lack the knowledge to identify people with axial spondyloarthritis, ...

Hansel Lui discusses inadequacies in healthcare education regarding chronic pain management in Canada and opportunities to ...

In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.

Chronic conditions that require long-term care will typically necessitate dietary adjustments and prescription medications. More serious conditions will require careful diagnosis and a treatment plan ...

This condition can be extremely difficult to manage, making effective treatment options essential. “Chronic pain disproportionately affects women, yet preclinical studies largely focus on males, ...

Objectives We aimed to estimate the prevalence of chronic bronchitis (CB), examine its association ... Methods A two-phased, cross-sectional design was used to analyse a random sample collected in ...

A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study, led by investigators at Johns ...

The team says systematically screening for these mental health conditions is critical when someone is seeking treatment for chronic pain, as is equitable access to care and innovative treatments.

Alberta is weighing a plan to ship hundreds of pallets of children ... and specifically will review the deal to import pain relievers from Turkey. MHCare has held $49.2-million in government ...

"This drug has significant implications for chronic pain treatment via peripheral CB1 activation but also could revolutionize the design of drugs targeting other [pain receptors]." The other ...